BMRN vs SEIC · P/E 40, rev $1.76B vs P/E 16, rev $1.26B
Biomarin Pharmaceutical Inc (BMRN) versus SEI Investments Company (SEIC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
SEI Investments Company (SEIC) is a asset management company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SEIC revenue for 2026-06-30 was $1.26B. Net income was $370.1M. SEIC currently screens at market cap $10.95B and trailing P/E 15.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SEIC currently screens at market cap $10.95B and trailing P/E 15.5.
Not investment advice. Open the BMRN and SEIC stock pages for the full models.
Not investment advice.